Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark W J Strachan

Showing results (41-50 of 106) with videos related to

Pageof 11
Sort By:
Clinical Endocrinology|August 6, 2019
Validated criteria for the interpretation of a single measurement of serum cortisol in the investigation of suspected adrenal insufficiencyScott D Mackenzie, Robert M Gifford, Luke D Boyle, et al.
Clinical Endocrinology|October 7, 2018
Predicting outcomes and complications following radioiodine therapy in Graves' thyrotoxicosisEi Thuzar Aung, Nicola N Zammitt, Anna R Dover, et al.
Diabetes Care|January 31, 2006
Improving metabolic control leads to better working memory in adults with type 2 diabetesChristopher M Ryan, Martin I Freed, Julie A Rood, et al.
Atherosclerosis|August 5, 2017
Comparison of non-traditional biomarkers, and combinations of biomarkers, for vascular risk prediction in people with type 2 diabetes: The Edinburgh Type 2 Diabetes StudyAnna H Price, Christopher J Weir, Paul Welsh, et al.
Plos One|September 14, 2012
Association of N-terminal pro-brain natriuretic peptide with cognitive function and depression in elderly people with type 2 diabetesInsa Feinkohl, Naveed Sattar, Paul Welsh, et al.
Neurobiology of Aging|April 6, 2012
Serum leptin and cognitive function in people with type 2 diabetesJavier Labad, Jacqueline F Price, Mark W J Strachan, et al.
Diabetologia|October 16, 2020
Depression as a risk factor for dementia in older people with type 2 diabetes and the mediating effect of inflammationAlistair L Carr, Anniek J Sluiman, Sheila M Grecian, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 11, 2024
Outcomes after 1 year in adults using Omnipod 5: Real-world data from a UK diabetes centreRoland H Stimson, Mark W J Strachan, Anna R Dover, et al.
Diabetologia|June 23, 2021
Retinal arteriolar tortuosity and fractal dimension are associated with long-term cardiovascular outcomes in people with type 2 diabetesEmmanuel Sandoval-Garcia, Stela McLachlan, Anna H Price, et al.
Kidney International|June 22, 2012
Measuring urinary tubular biomarkers in type 2 diabetes does not add prognostic value beyond established risk factorsBryan R Conway, Deepika Manoharan, Divya Manoharan, et al.
Pageof 11

Showing results (41-50 of 106) with videos related to

Sort By:
Pageof 11
Clinical Endocrinology|August 6, 2019
Validated criteria for the interpretation of a single measurement of serum cortisol in the investigation of suspected adrenal insufficiencyScott D Mackenzie, Robert M Gifford, Luke D Boyle, et al.
Clinical Endocrinology|October 7, 2018
Predicting outcomes and complications following radioiodine therapy in Graves' thyrotoxicosisEi Thuzar Aung, Nicola N Zammitt, Anna R Dover, et al.
Diabetes Care|January 31, 2006
Improving metabolic control leads to better working memory in adults with type 2 diabetesChristopher M Ryan, Martin I Freed, Julie A Rood, et al.
Atherosclerosis|August 5, 2017
Comparison of non-traditional biomarkers, and combinations of biomarkers, for vascular risk prediction in people with type 2 diabetes: The Edinburgh Type 2 Diabetes StudyAnna H Price, Christopher J Weir, Paul Welsh, et al.
Plos One|September 14, 2012
Association of N-terminal pro-brain natriuretic peptide with cognitive function and depression in elderly people with type 2 diabetesInsa Feinkohl, Naveed Sattar, Paul Welsh, et al.
Neurobiology of Aging|April 6, 2012
Serum leptin and cognitive function in people with type 2 diabetesJavier Labad, Jacqueline F Price, Mark W J Strachan, et al.
Diabetologia|October 16, 2020
Depression as a risk factor for dementia in older people with type 2 diabetes and the mediating effect of inflammationAlistair L Carr, Anniek J Sluiman, Sheila M Grecian, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 11, 2024
Outcomes after 1 year in adults using Omnipod 5: Real-world data from a UK diabetes centreRoland H Stimson, Mark W J Strachan, Anna R Dover, et al.
Diabetologia|June 23, 2021
Retinal arteriolar tortuosity and fractal dimension are associated with long-term cardiovascular outcomes in people with type 2 diabetesEmmanuel Sandoval-Garcia, Stela McLachlan, Anna H Price, et al.
Kidney International|June 22, 2012
Measuring urinary tubular biomarkers in type 2 diabetes does not add prognostic value beyond established risk factorsBryan R Conway, Deepika Manoharan, Divya Manoharan, et al.
Pageof 11